11. |
Accrued Expenses and Other Long-Term Liabilities |
Other accrued expenses consisted
of the following as of December 31, 2019 and 2018:
|
|
December 31, 2019 |
|
|
December 31, 2018 |
|
Accrued royalties |
|
$ |
1,934 |
|
|
$ |
1,399 |
|
Indemnification liability |
|
|
- |
|
|
|
875 |
|
Contingent consideration |
|
|
502 |
|
|
|
434 |
|
Operating lease liability |
|
|
1,321 |
|
|
|
- |
|
Financing lease liability |
|
|
184 |
|
|
|
- |
|
Deferred revenue |
|
|
457 |
|
|
|
- |
|
Payable to CGI |
|
|
888 |
|
|
|
- |
|
Accrued sales and marketing - diagnostics |
|
|
197 |
|
|
|
- |
|
Accrued lab costs - diagnostics |
|
|
163 |
|
|
|
150 |
|
Accrued professional fees |
|
|
1,399 |
|
|
|
701 |
|
Taxes payable |
|
|
403 |
|
|
|
285 |
|
Unclaimed property |
|
|
565 |
|
|
|
565 |
|
All others |
|
|
1,366 |
|
|
|
682 |
|
Total other accrued expenses |
|
$ |
9,379 |
|
|
$ |
5,091 |
|
Other long-term liabilities consisted
of the following as of December 31, 2019 and 2018:
|
|
December 31, 2019 |
|
|
December 31, 2018 |
|
Warrant liability |
|
$ |
82 |
|
|
$ |
361 |
|
Uncertain tax positions |
|
|
4,081 |
|
|
|
3,838 |
|
Deferred revenue |
|
|
269 |
|
|
|
- |
|
Other |
|
|
141 |
|
|
|
120 |
|
Total other long-term liabilities |
|
$ |
4,573 |
|
|
$ |
4,319 |
|
|